|
Post by peppy on Jul 14, 2019 19:31:47 GMT -5
you are right, I was wrong. It is Switching to a liposomal amphotericin B (5 mg/kg daily) could be considered if the patient is clinically unresponsive to echinocandin treatment or has persistent fungemia for >5 days. www.cdc.gov/fungal/candida-auris/c-auris-treatment.htmlCorrection, MNKD has Tobramycin on the pipeline list. Amphoterican B was once on the pipeline list.
|
|